International consensus on the use of [<sup>18</sup>F]-FDG PET/CT in pediatric patients affected by epilepsy.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 34453559.
- Also identified by DOI 10.1007/s00259-021-05524-8.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Positron emission tomography (PET) with <sup>18</sup>F-fluorodeoxyglucose ([<sup>18</sup>F]-FDG) has been increasingly applied in precise localization of epileptogenic focus in epilepsy patients, including pediatric patients. The aim of this international consensus is to provide the guideline and specific considerations for [<sup>18</sup>F]-FDG PET in pediatric patients affected by epilepsy. An international, multidisciplinary task group is formed, and the guideline for brain [<sup>18</sup>F]-FDG PET/CT in pediatric epilepsy patients has been discussed and approved, which include but not limited to the clinical indications, patient preparation, radiopharmaceuticals and administered activities, image acquisition, image processing, image interpretation, documentation and reporting, etc. CONCLUSION: This is the first international consensus and practice guideline for brain [<sup>18</sup>F]-FDG PET/CT in pediatric epilepsy patients. It will be an international standard for this purpose in clinical practice.
Medical subject headings
- Epilepsy
- Fluorodeoxyglucose F18